Legend Biotech Corporation
LEGN
$18.55
-$0.55-2.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -296.80M | -239.68M | -325.31M | -218.12M | -177.00M |
| Total Depreciation and Amortization | 28.90M | 23.33M | 21.36M | 20.88M | 21.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 260.80M | 151.40M | 217.19M | 83.21M | -6.80M |
| Change in Net Operating Assets | -93.10M | -105.10M | -187.91M | -149.23M | 18.40M |
| Cash from Operations | -100.20M | -170.04M | -274.66M | -263.27M | -144.00M |
| Capital Expenditure | -28.60M | -18.60M | -15.66M | -9.86M | -14.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 738.20M | 1.82M | 347.96M | -187.96M | -836.50M |
| Cash from Investing | 709.60M | -16.78M | 332.29M | -197.81M | -850.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.60M | -3.56M | -4.12M | -4.02M | -4.00M |
| Issuance of Common Stock | 3.30M | 3.58M | 7.71M | 9.56M | 9.70M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -300.00K | 16.00K | 3.59M | 5.54M | 5.70M |
| Foreign Exchange rate Adjustments | 6.10M | 6.39M | 4.08M | -357.00K | -2.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 615.20M | -180.42M | 65.30M | -455.91M | -991.00M |